Ökmen Korgün, Metin Ökmen Burcu
Bursa Yuksek Ihtisas Training and Research Hospital, Anesthesiology and Reanimation, Bursa, Turkey.
Bursa Yuksek Ihtisas Training and Research Hospital, Physical Medicine and Rehabilitation, Bursa, Turkey.
Lasers Med Sci. 2017 Jan;32(1):137-142. doi: 10.1007/s10103-016-2095-4. Epub 2016 Oct 21.
This study aims to investigate the efficacy of three different percutaneous intradiscal therapies in patients with chronic low back pain (CLBP) due to lumbar disc herniation (LDH). Medical files of a total of 120 patients who received percutaneous intradiscal therapy were retrospectively analyzed. All patients were divided into three groups: group L: diode laser (n = 40), group R: radiofrequency (RF) (n = 40), and group P: pulsed radiofrequency (PRF) (n = 40). The visual analogue scale (VAS) and Oswestry Disability Index (ODI) scores were calculated at 1, 3, 6, and 12 months for all patients. One-year follow-up results were as follows: group L: pre-treatment (PreT) VAS 5.6 ± -1, ODI 37.6 ± -4.7, post-treatment 12th month (PT12) VAS 2.8 ± -1.4, ODI 14.1 ± -7.1; group P: PreT VAS 6.0 ± 1, ODI 37.5 ± 5.9, PT12 VAS 3.1 ± 1.3, ODI 20.3 ± 17.0; and group R: PreT VAS 5.6 ± 1.0, ODI 37.9 ± 4.7, PT12 VAS 3.3 ± 1.4, ODI 27.2 ± 14.1. In each of the three groups, there was a statistically significant reduction in the VAS and ODI scores at 1, 3, 6, and 12 months, compared to the baseline values (p < 0.05). The highest reduction in the VAS and ODI scores was observed in group L, whereas the lowest reduction was in group R. We consider that in groups with patient selection criteria at our study; diode laser, RF, and PRF, which are administered using the percutaneous intradiscal route for CLBP patients diagnosed with LDH, may be used as an alternative treatment option.
本研究旨在探讨三种不同的经皮椎间盘内治疗方法对因腰椎间盘突出症（LDH）导致慢性下腰痛（CLBP）患者的疗效。对总共120例接受经皮椎间盘内治疗的患者的病历进行回顾性分析。所有患者分为三组：L组：二极管激光治疗（n = 40），R组：射频（RF）治疗（n = 40），P组：脉冲射频（PRF）治疗（n = 40）。在1、3、6和12个月时计算所有患者的视觉模拟量表（VAS）和Oswestry功能障碍指数（ODI）评分。一年随访结果如下：L组：治疗前（PreT）VAS为5.6± -1，ODI为37.6± -4.7，治疗后第12个月（PT12）VAS为2.8± -1.4，ODI为14.1± -7.1；P组：PreT VAS为6.0±1，ODI为37.5±5.9，PT12 VAS为3.1±1.3，ODI为20.3±17.0；R组：PreT VAS为5.6±1.0，ODI为37.9±4.7，PT12 VAS为3.3±1.4，ODI为27.2±14.1。在三组中，与基线值相比，在1、3、6和12个月时VAS和ODI评分均有统计学意义的降低（p < 0.05）。VAS和ODI评分降低幅度最高的是L组，而降低幅度最低的是R组。我们认为，在我们研究中有患者选择标准的分组中；对于诊断为LDH的CLBP患者，采用经皮椎间盘内途径给予的二极管激光、RF和PRF可作为一种替代治疗选择。
